Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

463.73 -0.39 (-0.08%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vertex Pharmaceuticals

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
48 49 Next >
7 Cream-of-the-Crop Stocks to Buy Today
Fast-growing, underappreciated stocks to buy are trading at a steep discount and will reward investors as they rise in value. 
Via InvestorPlace
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength. 
Via Talk Markets
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?
Last year paved the way for a potential breakthrough this year for both gene-editing biotech companies. 
Via The Motley Fool
BP Stock, Baidu Lead 5 Stocks Near Buy Points With Big Growth Potential
BP and Chinese search leader Baidu lead this weekend's watch list. 
Via Investor's Business Daily
3 Smart Stocks to Buy if a Recession Is on the Way
Their products will enjoy strong demand regardless of what happens with the economy. 
Via The Motley Fool
The Latest Analyst Ratings for Vertex Pharmaceuticals
Via Benzinga
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
Via Benzinga
5 Reasons to Buy Vertex Pharmaceuticals Now
Vertex shares are extending last year's gains, and that trend probably isn't over. 
Via The Motley Fool
3 Dirt Cheap Stocks to Buy in January
Bargains can easily be found as the new year gets underway. 
Via The Motley Fool
The Best Stocks to Invest $5,000 In Right Now
It's still a great time to be a long-term investor. 
Via The Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
The healthcare industry isn't going anywhere. 
Via The Motley Fool
Incyte Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
On Thursday, Incyte stock hit a key performance benchmark, with its Relative Strength (RS) Rating jumping to 82, up from 78 the day before. 
Via Investor's Business Daily
3 Unstoppable Stocks to Keep Buying in 2023
These companies have what it takes to drive long-term share performance. 
Via The Motley Fool
Vertex Pharmaceuticals Stock Meets 80-Plus Relative Strength Rating Benchmark
Putting together your watch list? Look for stocks with an 80-plus RS Rating. Vertex Pharmaceuticals stock meets that criteria, rising to 84. 
Via Investor's Business Daily
7 Biotech Stocks That Will Make You Rich in 10 Years
Although the health innovation space is risky, the opportunities beckon a look at the biotech stocks that will make you rich in 10 years. 
Via InvestorPlace
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Vertex is heading for a new phase of growth. 
Via The Motley Fool
1 Top Growth Stock Set to Crush the Market Again in 2023
This company's long-term thesis looks impeccable. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
Via Benzinga
3 Biopharma Stocks That Could Help Make You a Fortune
All three are protected by sales of in-demand products, with more on the way. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
Via Benzinga
2 Stocks Down More Than 25% to Buy Right Now
These companies are set for a new era of growth. 
Via The Motley Fool
5 Potentially Explosive Stocks to Buy in 2023
These stocks all dropped in the double digits last year. But their future prospects are brilliant. 
Via The Motley Fool
Want to Get Richer? 3 Top Stocks to Buy Now and Hold Forever
Expect these stocks to boost your portfolio in the long run. 
Via The Motley Fool
2 Top Healthcare Stocks to Buy for the Long Haul
This space is rife with opportunity for investors. 
Via The Motley Fool
4 Growth Stocks to Buy and Hold Forever
These stocks could be huge winners for patient investors. 
Via The Motley Fool
Vertex Pharmaceuticals Stock Sees Rising Relative Strength
A Relative Strength Rating upgrade for Vertex Pharmaceuticals shows improving technical performance. Will it continue? 
Via Investor's Business Daily
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
These healthcare companies' revenue and earnings have grown, and they expect more growth. 
Via The Motley Fool
3 Top Healthcare Stocks to Buy for January
These healthcare stocks have a lot going for them in the new year. 
Via The Motley Fool
2 Supercharged Stocks to Buy Right Now That Could Soar in 2023
These stocks have been solid performers despite the macroeconomic uncertainties in 2022. 
Via The Motley Fool
2 Growth Stocks That Could Help Set You Up for Life
Regularly investing in both up and down markets can help you build a resilient portfolio over time. 
Via The Motley Fool
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.